Anxiety and Cardiac Disease Mechanisms

How it works

Risks & contraindications

Highlighted claims

• Physiological pathways linking anxiety and cardiac disease include autonomic nervous system dysregulation and HPA axis dysregulation. — Prevalence and types of anxiety disorders among patients with cardiac conditions and elevated HADS-A scores: findings from the initial screening phase of the Heart and Mind trial in Denmark
• Anxiety can influence cardiac risk behaviours such as smoking, obesity, excessive alcohol use, unhealthy diet, physical inactivity, and low treatment adherence. — Prevalence and types of anxiety disorders among patients with cardiac conditions and elevated HADS-A scores: findings from the initial screening phase of the Heart and Mind trial in Denmark
• Autonomic and HPA-axis changes may increase cortisol and catecholamine levels and decrease heart rate variability. — Prevalence and types of anxiety disorders among patients with cardiac conditions and elevated HADS-A scores: findings from the initial screening phase of the Heart and Mind trial in Denmark
• Behavioural pathways related to anxiety may worsen cardiovascular risk and outcomes. — Prevalence and types of anxiety disorders among patients with cardiac conditions and elevated HADS-A scores: findings from the initial screening phase of the Heart and Mind trial in Denmark
• Cardiac disease itself can become a source of anxiety for patients. — Prevalence and types of anxiety disorders among patients with cardiac conditions and elevated HADS-A scores: findings from the initial screening phase of the Heart and Mind trial in Denmark